Literature DB >> 16785219

Antidepressant treatment patterns in a novel methadone maintenance clinic targeting young adults an observational study.

David W Galarneau1, Jedediah J Teres, Andrew C Leon, Dorothy Melia, Charles Lilly, Scott Kellogg, Elizabeth Khuri, Mary Jeanne Kreek.   

Abstract

This observational study examined the antidepressant treatment patterns of a novel New York City methadone maintenance treatment program (MMTP), founded for the treatment of adolescents and now targeting young adults and older patients with special problems. The goal of the study was to investigate demographic or clinical characteristics that were associated with prescribing patterns, as well as whether antidepressant use was associated with sobriety. The method of data collection was a thorough chart review. Antidepressant treatment was significantly associated with gender, education, marital status, and relapse. However, after controlling for demographic and clinical characteristics, antidepressant treatment was not significantly associated with a reduction in relapse risk. Further research is needed to explore these relationships, as well as their generalizability to adult methadone clinics, and to examine the underlying factors that lead to similarities and distinctions in antidepressant prescribing practices between various types of clinics (i.e., general outpatient vs. methadone maintenance).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785219     DOI: 10.1300/j069v25n02_07

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  2 in total

1.  Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment.

Authors:  Daniel Rosen; Jennifer Q Morse; Charles F Reynolds
Journal:  J Subst Abuse Treat       Date:  2010-10-30

Review 2.  Bidirectional translational research: Progress in understanding addictive diseases.

Authors:  M J Kreek; S D Schlussman; B Reed; Y Zhang; D A Nielsen; O Levran; Y Zhou; E R Butelman
Journal:  Neuropharmacology       Date:  2008-08-07       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.